Published in Arterioscler Thromb Vasc Biol on March 11, 2004
Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats. Respir Res (2010) 1.00
Human IL-8 regulates smooth muscle cell VCAM-1 expression in response to endothelial cells exposed to atheroprone flow. Arterioscler Thromb Vasc Biol (2009) 0.96
Fermented soshiho-tang with Lactobacillus plantarum enhances the antiproliferative activity in vascular smooth muscle cell. BMC Complement Altern Med (2014) 0.81
Cyclic stretch affects pulmonary endothelial cell control of pulmonary smooth muscle cell growth. Am J Respir Cell Mol Biol (2008) 0.80
Control of smooth muscle cell activation. Arterioscler Thromb Vasc Biol (2004) 0.77
Herbal composition of Cinnamomum cassia, Pinus densiflora, Curcuma longa and Glycyrrhiza glabra prevents atherosclerosis by upregulating p27 (Kip1) expression. BMC Complement Altern Med (2016) 0.76
High glucose concentration induces endothelial cell proliferation by regulating cyclin-D2-related miR-98. J Cell Mol Med (2016) 0.76
Murrayafoline A Induces a G0/G1-Phase Arrest in Platelet-Derived Growth Factor-Stimulated Vascular Smooth Muscle Cells. Korean J Physiol Pharmacol (2015) 0.75
Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res (2008) 8.49
Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med (2003) 8.46
Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med (2005) 7.66
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J (2006) 5.93
Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med (2002) 4.05
MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res (2012) 3.53
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet (2012) 3.20
Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther (2006) 2.85
Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation (2003) 2.27
A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors. JAMA (2012) 2.25
An initiative in mentoring to promote residents' and faculty members' careers. Acad Med (2004) 1.95
Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol (2010) 1.95
Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension (2006) 1.91
Atherosclerosis 2005: recent discoveries and novel hypotheses. Circulation (2005) 1.87
Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell (2007) 1.72
Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation (2002) 1.67
Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res (2010) 1.60
Molecular genetics and genomics of heart failure. Nat Rev Genet (2004) 1.60
Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics (2002) 1.57
Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction. Proc Natl Acad Sci U S A (2010) 1.51
Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells (2009) 1.50
Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res (2006) 1.46
Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation (2004) 1.46
Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation (2004) 1.41
Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol (2002) 1.38
Improving the health of the community: Duke's experience with community engagement. Acad Med (2008) 1.38
Time-course analysis on the differentiation of bone marrow-derived progenitor cells into smooth muscle cells during neointima formation. Arterioscler Thromb Vasc Biol (2010) 1.36
Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a. J Mol Cell Cardiol (2008) 1.35
Cell cycle dependent morphology changes and associated mitochondrial DNA redistribution in mitochondria of human cell lines. Mitochondrion (2002) 1.35
Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol (2005) 1.32
Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. Circulation (2004) 1.22
Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther (2010) 1.19
Perspective: global medicine: opportunities and challenges for academic health science systems. Acad Med (2011) 1.17
Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway. J Mol Cell Cardiol (2007) 1.15
Training the next generation of physician-executives: an innovative residency pathway in management and leadership. Acad Med (2011) 1.14
Liver X receptors alpha and beta regulate renin expression in vivo. J Clin Invest (2005) 1.13
Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-/-)/low-density lipoprotein(-/-) double knockout mice. Arterioscler Thromb Vasc Biol (2005) 1.12
Quantitative X-ray imaging of intraplaque hemorrhage in aortas of apoE(-/-)/LDL(-/-) double knockout mice. Invest Radiol (2007) 1.11
SFRP2 regulates cardiomyogenic differentiation by inhibiting a positive transcriptional autofeedback loop of Wnt3a. Stem Cells (2007) 1.09
Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function. FASEB J (2006) 1.09
Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. Proc Natl Acad Sci U S A (2004) 1.09
Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics (2003) 1.06
Nuclear receptor LXRalpha is involved in cAMP-mediated human renin gene expression. Mol Cell Endocrinol (2004) 1.06
The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol Biol Cell (2003) 1.04
Construction of a zebrafish cDNA microarray: gene expression profiling of the zebrafish during development. Biochem Biophys Res Commun (2002) 1.01
Biomimetic matrices for myocardial stabilization and stem cell transplantation. J Biomed Mater Res A (2010) 1.00
Endothelium-targeted gene and cell-based therapies for cardiovascular disease. Arterioscler Thromb Vasc Biol (2004) 0.99
Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease. Circulation (2002) 0.98
Physiological genomics of cardiac disease: quantitative relationships between gene expression and left ventricular hypertrophy. Physiol Genomics (2006) 0.98
Identification of calcium-modulating cyclophilin ligand (CAML) as transducer of angiotensin II-mediated nuclear factor of activated T cells (NFAT) activation. J Biol Chem (2005) 0.96
Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction. Am J Physiol Heart Circ Physiol (2007) 0.95
Risk factor criteria. Circulation (2004) 0.95
Clustering and heritability of insulin resistance in Chinese and Japanese hypertensive families: a Stanford-Asian Pacific Program in Hypertension and Insulin Resistance sibling study. Hypertens Res (2002) 0.95
Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation (2005) 0.94
Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness. Circulation (2003) 0.94
Adult renal mesenchymal stem cell-like cells contribute to juxtaglomerular cell recruitment. J Am Soc Nephrol (2013) 0.93
Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction. Am J Physiol Heart Circ Physiol (2009) 0.93
Transcription factor decoy. Circ Res (2002) 0.92
Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation. Basic Res Cardiol (2012) 0.92
A global partnership in medical education between Duke University and the National University of Singapore. Acad Med (2008) 0.91
Abi3bp is a multifunctional autocrine/paracrine factor that regulates mesenchymal stem cell biology. Stem Cells (2013) 0.91
Genetic markers: progress and potential for cardiovascular disease. Circulation (2004) 0.91
Circulating smooth muscle progenitor cells in arterial remodeling. J Mol Cell Cardiol (2010) 0.91
Genetic interventions for vein bypass graft disease: a review. J Vasc Surg (2002) 0.90
Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery. J Am Coll Cardiol (2006) 0.90
Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol (2004) 0.90
Rapid analysis of mitochondrial DNA depletion by fluorescence in situ hybridization and immunocytochemistry: potential strategies for HIV therapeutic monitoring. J Histochem Cytochem (2004) 0.89
Identification of a novel set of genes regulated by a unique liver X receptor-alpha -mediated transcription mechanism. J Biol Chem (2003) 0.89
VATS lobectomy facilitates the delivery of adjuvant docetaxel-carboplatin chemotherapy in patients with non-small cell lung cancer. J Thorac Dis (2013) 0.88
Mesenchymal stem cells differentiate into renin-producing juxtaglomerular (JG)-like cells under the control of liver X receptor-alpha. J Biol Chem (2010) 0.88
Distinctive ERK and p38 signaling in remote and infarcted myocardium during post-MI remodeling in the mouse. J Cell Biochem (2010) 0.88
Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? Circulation (2004) 0.88
Enhancing stem cell therapy through genetic modification. J Am Coll Cardiol (2005) 0.88
Preclinical evaluation of inducible nitric oxide synthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesion formation. Hum Gene Ther (2003) 0.87
Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury. Int Immunol (2009) 0.86
Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach. Physiol Genomics (2003) 0.86
C3orf58, a novel paracrine protein, stimulates cardiomyocyte cell-cycle progression through the PI3K-AKT-CDK7 pathway. Circ Res (2013) 0.86
Caffeinated sugar-sweetened beverages and common physical complaints in Icelandic children aged 10-12 years. Prev Med (2014) 0.86
Chromosomal distribution of the human cardiovascular transcriptome. Genomics (2003) 0.85
Heart failure switches the RV alpha1-adrenergic inotropic response from negative to positive. Am J Physiol Heart Circ Physiol (2009) 0.85
Direct reprogramming of cardiac fibroblasts to cardiomyocytes using microRNAs. Methods Mol Biol (2014) 0.84
Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. Anesth Analg (2004) 0.84
Factor Seven Activating Protease (FSAP) expression in human monocytes and accumulation in unstable coronary atherosclerotic plaques. Atherosclerosis (2007) 0.83
An immunocytochemical approach to detection of mitochondrial disorders. J Histochem Cytochem (2002) 0.83
Evolving revascularization approaches for myocardial ischemia. Am J Cardiol (2003) 0.82
Inhibition of matrix deposition: a new strategy for prevention of restenosis after balloon angioplasty. J Cardiovasc Pharmacol (2010) 0.81
3-Deazaadenosine inhibits vasa vasorum neovascularization in aortas of ApoE(-/-)/LDL(-/-) double knockout mice. Atherosclerosis (2008) 0.81
Molecular mechanism of juxtaglomerular cell hyperplasia: a unifying hypothesis. J Am Soc Hypertens (2010) 0.81
Gene and cell-based therapies for heart disease. FASEB J (2004) 0.81
Myocardial survival signaling in response to stem cell transplantation. J Am Coll Surg (2009) 0.81
CCAAT/enhancer-binding protein decoy oligodeoxynucleotide inhibition of macrophage-rich vascular lesion formation in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol (2002) 0.80
Fostering creativity: how the Duke Graduate Medical Education Quasi-Endowment encourages innovation in GME. Acad Med (2013) 0.80
Anti-atherosclerotic mechanisms of statin therapy. Curr Opin Pharmacol (2013) 0.80
MEK1-induced physiological hypertrophy inhibits chronic post-myocardial infarction remodeling in mice. J Cell Biochem (2013) 0.80
Potential for germ line transmission after intramyocardial gene delivery by adeno-associated virus. Biochem Biophys Res Commun (2004) 0.80
Genetic therapies for cardiovascular diseases. Trends Mol Med (2005) 0.79
Bioluminescence resonance energy transfer identify scaffold protein CNK1 interactions in intact cells. FEBS Lett (2005) 0.78